Arrowhead Research, the parent company of RNAi drugs startup Calando Pharmaceuticals, said that it has named Thomas Tombrello to its scientific advisory board.
Tombrello is chairman of the division of physics, mathematics, and astronomy at the California Institute of Technology. He is also the institute's technology assessment officer, Arrowhead said.
Michael Monko has become vice president of sales for the research products segment of Serologicals. That segment consists of Chemicon International and the Upstate Group.
Monko comes to Serologicals from Invitrogen, where for almost more than 20 years he held a number of sales positions. Most recently, he was the senior director of sales force effectiveness.
He holds an MBA from Babson College in Wellesley, Mass., and a BS in biochemistry from the University of New Hampshire.